BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30902399)

  • 1. Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors.
    Lozinskaya NA; Babkov DA; Zaryanova EV; Bezsonova EN; Efremov AM; Tsymlyakov MD; Anikina LV; Zakharyascheva OY; Borisov AV; Perfilova VN; Tyurenkov IN; Proskurnina MV; Spasov AA
    Bioorg Med Chem; 2019 May; 27(9):1804-1817. PubMed ID: 30902399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
    Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
    Francisco CS; Javarini CL; de S Barcelos I; Morais PAB; de Paula H; de S Borges W; Neto ÁC; Lacerda V
    Curr Top Med Chem; 2020; 20(2):153-160. PubMed ID: 31648640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues.
    Han S; Zhou W; Zhuang C; Chen F
    Bioorg Chem; 2022 Feb; 119():105537. PubMed ID: 34902644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis and Biological Evaluation of 7-Chloro-9
    Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new GSK-3β inhibitors through structure-based virtual screening.
    Dou X; Jiang L; Wang Y; Jin H; Liu Z; Zhang L
    Bioorg Med Chem Lett; 2018 Jan; 28(2):160-166. PubMed ID: 29208522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.
    Hulcová D; Breiterová K; Siatka T; Klímová K; Davani L; Šafratová M; Hošťálková A; De Simone A; Andrisano V; Cahlíková L
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29561817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.
    Redenti S; Marcovich I; De Vita T; Pérez C; De Zorzi R; Demitri N; Perez DI; Bottegoni G; Bisignano P; Bissaro M; Moro S; Martinez A; Storici P; Spalluto G; Cavalli A; Federico S
    ChemMedChem; 2019 Feb; 14(3):310-314. PubMed ID: 30548443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
    Yang Z; Liu H; Pan B; He F; Pan Z
    Org Biomol Chem; 2018 Jun; 16(22):4127-4140. PubMed ID: 29781013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer.
    Gao Y; Ye DY; Zhou WC; Chu Y
    Eur J Med Chem; 2017 Jul; 135():370-381. PubMed ID: 28460311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of pyrimidin-4-one-1,2,3-triazole conjugates as glycogen synthase kinase-3β inhibitors with anti-depressant activity.
    Khan I; Tantray MA; Hamid H; Alam MS; Kalam A; Hussain F; Dhulap A
    Bioorg Chem; 2016 Oct; 68():41-55. PubMed ID: 27454617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.
    Kohara T; Nakayama K; Watanabe K; Kusaka SI; Sakai D; Tanaka H; Fukunaga K; Sunada S; Nabeno M; Saito KI; Eguchi JI; Mori A; Tanaka S; Bessho T; Takiguchi-Hayashi K; Horikawa T
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3733-3738. PubMed ID: 28712706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis and in Vitro Tumor Cytotoxicity Evaluation of 3,5-Diamino-N-substituted Benzamide Derivatives as Novel GSK-3β Small Molecule Inhibitors.
    Zhou Y; Zhang L; Fu X; Jiang Z; Tong R; Shi J; Li J; Zhong L
    Chem Biodivers; 2019 Sep; 16(9):e1900304. PubMed ID: 31338947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
    Shi XL; Wu JD; Liu P; Liu ZP
    Eur J Med Chem; 2019 Apr; 167():211-225. PubMed ID: 30772605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.
    Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB
    Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors.
    Arfeen M; Bhagat S; Patel R; Prasad S; Roy I; Chakraborti AK; Bharatam PV
    Eur J Med Chem; 2016 Oct; 121():727-736. PubMed ID: 27423119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review.
    Xu M; Wang SL; Zhu L; Wu PY; Dai WB; Rakesh KP
    Eur J Med Chem; 2019 Feb; 164():448-470. PubMed ID: 30616053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation and energetic analyses of novel GSK-3β inhibitors.
    Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X
    J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.